Amgen reportedly in talks to buy Horizon Therapeutics
Amgen Inc. is in advanced talks to buy drug company Horizon Therapeutics PLC, according to people familiar with the matter, in a takeover likely to be valued at well over $20 billion and mark the largest healthcare merger of the year. The U.S. biotechnology company AMGN, -2.42% was the last of three suitors standing in an auction for Horizon HZNP, +0.39%, the…